State of Wisconsin Investment Board
CERE

State of Wisconsin Investment Board’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

State of Wisconsin Investment Board’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-367,973
Closed -$15M – 2393
2024
Q2 		$15M Buy
367,973
+24,155
+7% +$1.01M 0.04% 407
2024
Q1 		$14.5M Buy
343,818
+285,521
+490% +$12M 0.04% 453
2023
Q4 		$2.47M Buy
58,297
+5,727
+11% +$165K 0.01% 1196
2023
Q3 		$1.15M Sell
52,570
-2,177
-4% -$54.5K ﹤0.01% 1363
2023
Q2 		$1.74M Sell
54,747
-2,925
-5% -$89.8K ﹤0.01% 1335
2023
Q1 		$1.41M Sell
57,672
-4,795
-8% -$141K ﹤0.01% 1388
2022
Q4 		$1.97M Buy
62,467
+2,916
+5% +$82.3K 0.01% 1323
2022
Q3 		$1.68M Buy
59,551
+7,993
+16% +$238K 0.01% 1384
2022
Q2 		$1.36M Sell
51,558
-2,142
-4% -$60.8K ﹤0.01% 1485
2022
Q1 		$1.88M Hold
53,700
– – ﹤0.01% 1516
2021
Q4 		$1.74M Buy
53,700
+8,100
+18% +$286K ﹤0.01% 1305
2021
Q3 		$1.34M Hold
45,600
– – ﹤0.01% 1370
2021
Q2 		$1.17M Buy
+45,600
New +$653K ﹤0.01% 1406

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

State of Wisconsin Investment Board's CERE Position: Q3 2024 in Review

State of Wisconsin Investment Board sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 367,973 shares — an estimated $15M sold.

State of Wisconsin Investment Board first reported a position in CERE in Q2 2021 and held it in 13 quarters. The position peaked at $15M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • State of Wisconsin Investment Board reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 367,973 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $15M.
  • State of Wisconsin Investment Board first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • State of Wisconsin Investment Board's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $15M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2024, filed 14 Nov 2024.